Laboratory Corp. of America Holdings (LH) Pops 2.79% for February 10

Equities Staff |

One of the S&P 500’s big winners for Wednesday February 10 was Laboratory Corp. of America Holdings (LH) as the company’s stock climbed 2.79% to $105.39 on volume of 603,823 shares.

The stock opened at $102.73 and saw an intraday low of $102.46 and an intraday high of $106.82. All told, the day saw a per-share gain of $2.86. The stock’s average daily volume of 1.03 million and 101.2 million shares outstanding. Laboratory Corp. of America Holdings now has a 50-day SMA is $117.47 and 200-day SMA is $119.02, and it has a 52-week high of $131.19 and a 52-week low of $97.79.

Laboratory Corp of America Hldgs offers testing services used by the medical profession in core testing, patient diagnosis and in the monitoring and treatment of disease.

Based out of Burlington, NC, Laboratory Corp. of America Holdings has 48,000 employees and, after today’s trading, reached a market cap of $10.67 billion. The stock’s P/E Ratio is 22.6. Its P/S ratio is 1.63, P/B ratio is 2.17, and P/FCF ratio is -3.2.

For a complete fundamental analysis analysis of Laboratory Corp. of America Holdings, check out’s Stock Valuation Analysis report for LH. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

NABUfit Global Inc

NABUfit Global Inc develops online fitness portal and a mobile app with the option of connecting existing and future monitoring devices (wearables etc.).

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…